货号:GS40821
Zimberelimab (AB-122/GLS-010) is a fully human monoclonal antibody that targets the programmed cell death protein 1 (PD-1) receptor. It is an immune checkpoint inhibitor approved in China and under investigation globally for the treatment of various advanced solid tumors, including classical Hodgkin lymphoma, non-small cell lung cancer, and melanoma, aiming to restore anti-tumor T-cell activity.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物